SoftOx Solutions AS (DE:6FV) has released an update.
A recent study published in ‘Advances in Wound Care’ has confirmed the safety and effectiveness of SoftOx Solutions AS’s Biofilm Eradicator (SBE) in human patients, demonstrating not only its tolerability but also its ability to reduce bioburden and enhance wound healing.
For further insights into DE:6FV stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
